<DOC>
	<DOCNO>NCT01298726</DOCNO>
	<brief_summary>The purpose study examine effect pharmaceutical care program level glycated hemoglobin hyperglycemic user brazilian public health care system drug treatment type 2 diabetes .</brief_summary>
	<brief_title>Pharmaceutical Care Type 2 Diabetes</brief_title>
	<detailed_description>The chronic disease , include diabetes mellitus ( DM ) major public health problem today . There evidence glycated hemoglobin ( A1C ) level 7 % associate progressively great risk chronic complication relate DM . However , approximately 60 % diabetic achieve glycemic control . In Brazil , pharmacists involve direct care patient DM . The investigator conduct randomize controlled trial , six month , Ouro Preto , Minas terais determine effect pharmaceutical intervention glycemic control patient diabetes hyperglycemic ( A1C &gt; 7 % ) . One hundred twenty-nine subject randomize receive usual care usual care pharmaceutical intervention . The population access brazilian public health care system , consultation doctor , nurse nutritionist , laboratory test access essential medicine consider conventional health care .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>MINIMAL AGE 18 YEARS OLD USE OF DIABETES ORAL MEDICATION MINIMAL GLYCOHEMOGLOBIN 7 % PREGNANT AND NURSING WOMEN PEOPLE UNABLE TO ATTEND THE STUDY SITE PARTICIPANTS OF OTHER PROGRAMS OF PHARMACEUTICAL CARE</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>PHARMACEUTICAL SERVICES</keyword>
	<keyword>DIABETES MELLITUS</keyword>
</DOC>